Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1089/vim.2021.0022 http://scihub22266oqcxt.onion/10.1089/vim.2021.0022 34115949!?!34115949 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34115949&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Viral+Immunol 2021 ; 34 (8): 567-572 Nephropedia Template TP {{tp|p=34115949|t=2021. Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 |pdf=|usr=}}{{34115949}} gab.com Text Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 JO: Viral Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34115949 #FOAvip Interleukin-10 (IL-10) gene polymorphisms have been associated with severity and outcomes in patients with respiratory and nonrespiratory viral infections. The aim of this study was to assess whether rs1800871 and rs1800872 polymorphisms of IL-10 gene are associated with the clinical outcomes of COVID-19 in a Mexican population. Study subjects were 193 COVID-19 patients. The genotyping was carried out with real-time PCR and serum IL-10 levels were measured with enzyme-linked immunosorbent assay. Logistic regression analysis was used for analysis association with clinical outcomes. There was no evidence of an association between alleles, genotypes, or haplotypes frequencies between patient groups according to severity and outcomes. The rs1800871 and rs1800872 polymorphisms might not be genetic risk factors for severity and mortality for COVID-19 in Mexican mestizos patients from northwest Mexico. Twit Text FOAVip Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 ????Viral Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34115949 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34115949 #FOAvip English Wikipedia <ref>{{Cite pmid|34115949}}</ref> Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 #MMPMID34115949 Avendano-Felix M; Ochoa-Ramirez LA; Ramos-Payan R; Aguilar-Medina M; Ayala-Ham A; Rendon-Aguilar H; Lizarraga-Verdugo E; Peraza-Garay F; Rios-Tostado JJ; Velarde-Felix JS Viral Immunol 2021[Oct]; 34 (8): 567-572 PMID34115949show ga Interleukin-10 (IL-10) gene polymorphisms have been associated with severity and outcomes in patients with respiratory and nonrespiratory viral infections. The aim of this study was to assess whether rs1800871 and rs1800872 polymorphisms of IL-10 gene are associated with the clinical outcomes of COVID-19 in a Mexican population. Study subjects were 193 COVID-19 patients. The genotyping was carried out with real-time PCR and serum IL-10 levels were measured with enzyme-linked immunosorbent assay. Logistic regression analysis was used for analysis association with clinical outcomes. There was no evidence of an association between alleles, genotypes, or haplotypes frequencies between patient groups according to severity and outcomes. The rs1800871 and rs1800872 polymorphisms might not be genetic risk factors for severity and mortality for COVID-19 in Mexican mestizos patients from northwest Mexico. |*Polymorphism, Genetic[MESH] |Adult[MESH] |Aged[MESH] |Alleles[MESH] |COVID-19/*genetics/immunology/therapy[MESH] |Female[MESH] |Genotype[MESH] |Haplotypes[MESH] |Humans[MESH] |Interleukin-10/*genetics/metabolism[MESH] |Male[MESH] |Mexico[MESH] |Middle Aged[MESH]Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clin(epmc).pdf DeepDyve Pubget Overpricing